Founders ask: "Should I raise capital now?" The question contains a false premise. Fundraising is not a timing decision like buying equity in a bull market. It is a structural decision about whether external capital enables growth that internal financing cannot support.
The wrong reasons to raise capital
Most fundraising is mistimed because it is driven by the wrong triggers:
1. Market sentiment is favorable
In 2021, Indian SaaS companies raised at 40-50x revenue multiples. Founders who optimized for valuation alone raised at peak and faced structural pain 18 months later when down-rounds or flat extensions became necessary.
Market sentiment is not a strategy. If capital raised in favorable conditions is deployed poorly, the dilution compounds without creating proportional value.
2. Competitors are raising
A competitor's fundraise signals investor appetite in your space. It does not mean your business should raise at the same time or scale.
If your competitor is burning ₹10 crores/month to subsidize customer acquisition and you have sustainable unit economics, their fundraise may be a sign to stay disciplined — not to match their capital deployment.
3. Runway is running low
Fundraising with 3-4 months of runway is not strategic — it is reactive. Investors can sense desperation, and it shows in term sheets: lower valuations, harsher terms, fewer competitive offers.
Founders who wait until runway pressure forces fundraising give up negotiating leverage and often accept sub-optimal terms to avoid shutdown risk.
The right reason to raise capital
There is one valid reason to raise external capital:
Capital unlocks growth that cannot be financed from internal cash flow, and that growth creates defensible competitive advantage or market position that justifies the dilution.
This definition has three components, all of which must be true:
- Growth cannot be financed internally — If current cash flow or modest revenue-based financing can fund the next phase of growth, external equity is premature. Dilution should be reserved for step-function expansion that requires upfront capital before returns materialize.
- Growth creates defensible advantage — The capital must fund something that compounds: network effects, brand, proprietary data, regulatory moats, or operational scale that competitors cannot replicate cheaply.
- Dilution is justified by value creation — If raising ₹10 crores at a ₹50 crore post-money valuation (20% dilution) enables the business to reach ₹100 crore valuation in 18 months, the math works. If it funds 18 months of burn without meaningful progress, it does not.
A framework for deciding when to raise
Use this decision tree to evaluate whether fundraising makes sense:
Step 1: Define what the capital will fund
Be specific. "Scale the business" is not a use of funds. "Hire 15 enterprise sales reps to expand from 3 to 12 cities" is.
Examples of specific uses:
- Product development: Build feature X that unlocks enterprise segment (currently 10% of revenue, target 40%)
- Geographic expansion: Enter 5 new states requiring local compliance infrastructure, sales teams, and operational setup
- Customer acquisition: Scale paid marketing from ₹20L/month to ₹1Cr/month to capture market share before competitor Y launches
- Inventory/working capital: Stock 6 months of inventory to meet minimum order quantities for Tier 1 retail partnerships
Step 2: Model the business case with and without capital
Run two scenarios:
Scenario A: Bootstrap (internal financing only)
- Revenue growth: 50% YoY (constrained by hiring and marketing budget)
- Time to ₹10 crore ARR: 30 months
- Founder dilution: 0%
- Competitive risk: Moderate (slower growth allows competitor to capture market share)
Scenario B: Raise ₹8 crores at ₹40 crore post-money (20% dilution)
- Revenue growth: 150% YoY (enabled by aggressive sales hiring and market expansion)
- Time to ₹10 crore ARR: 15 months
- Founder dilution: 20% now, likely another 15-20% at Series A
- Competitive risk: Low (market leadership position secured before competitors scale)
If Scenario B reaches ₹100 crore valuation in 18 months, founders own 60-65% of ₹100 crores (₹60-65 crores). If Scenario A reaches ₹50 crore valuation in 30 months, founders own 100% of ₹50 crores.
The dilution is justified if the capital creates a larger pie faster. If not, bootstrap.
Step 3: Assess execution risk
Capital does not eliminate execution risk — it amplifies it. Raising ₹10 crores to scale a broken business model accelerates failure.
Before fundraising, validate:
- Product-market fit — Do customers pay willingly, renew consistently, and refer organically? If not, raising capital to find PMF is expensive experimentation.
- Unit economics — Is LTV > 3x CAC? If not, scaling acquisition burns capital without creating sustainable growth.
- Operational readiness — Can the team execute the plan? Hiring 20 people in 6 months requires recruitment infrastructure, onboarding systems, and management bandwidth. If those don't exist, the capital gets deployed inefficiently.
Step 4: Evaluate fundraising timing
Assuming the business case is sound and execution risk is manageable, timing matters for two reasons:
Runway
Begin fundraising with 12-18 months of runway. This gives you 6-9 months to run a process and 6-9 months of buffer if fundraising takes longer than expected or you choose to wait for better terms.
Momentum
Fundraise from a position of strength: growing revenue, improving margins, expanding customer base. Investors pay premium valuations for momentum. Fundraising during a trough (flat revenue, customer churn spike, co-founder departure) compresses valuation and attracts unfavorable terms.
How much capital to raise
Raise enough to achieve the next major inflection point plus 6 months of buffer.
Inflection points are milestones that materially change valuation or de-risk the business:
- Revenue milestones: ₹1 crore ARR (seed), ₹10 crore ARR (Series A), ₹50 crore ARR (Series B)
- Profitability: Reaching EBITDA breakeven or cash flow positive
- Product milestones: Launching v2.0 that enables enterprise sales
- Market position: Becoming #1 or #2 player in a defined category
Example: A SaaS company at ₹2 crore ARR targeting ₹10 crore ARR in 18 months should raise for 24 months of runway (18 months to milestone + 6 month buffer).
If the burn rate required to reach ₹10 crore ARR is ₹50 lakhs/month, raise:
24 months × ₹50L/month = ₹12 crores
Do not over-raise. Capital beyond what the business can deploy efficiently sits idle or encourages undisciplined spending. Under-raising forces another fundraise before reaching an inflection point, which often happens at unfavorable terms if traction has not materialized.
From whom to raise capital
Investor selection matters as much as valuation. The wrong investor at a high valuation is worse than the right investor at a moderate valuation.
Evaluate investors on three dimensions
1. Strategic alignment
Do they understand your market, have relevant portfolio companies, and operate at your stage? A growth-stage investor writing a seed check will impose Series B expectations on a Series A company.
2. Value-add beyond capital
Can they help with hiring, customer intros, subsequent fundraising, or strategic guidance? Not all investors add operational value — many are passive capital providers.
3. Fund structure and incentives
Early-stage funds (Fund I or II) need exits in 5-7 years to return capital to LPs. Later-stage funds have longer timelines. Misalignment on exit timeline creates conflict when the fund wants liquidity but the business is not ready.
Run a competitive process
One term sheet gives you one data point. Three term sheets give you market validation of valuation and terms.
Investors who see competing interest move faster and offer better terms. Those who sense single-option dynamics negotiate harder.
When NOT to raise capital
Do not raise if any of the following are true:
- The business can reach the next inflection point with internal financing — Every rupee of dilution should be justified by growth that cannot be self-funded. If you can grow 3x on current cash flow, wait until growth constraints require external capital.
- Product-market fit is unproven — Capital does not create PMF. It accelerates distribution of a product customers already want. Fundraising before PMF is expensive experimentation that often ends in down-rounds or shutdown.
- The team cannot execute the scale plan — If you plan to hire 30 people in 12 months but have never hired more than 5 people in a year, the capital will not deploy efficiently. Build execution muscle before taking institutional capital.
- Valuation expectations and market reality are misaligned — If comparable companies are raising at 8-10x revenue and you expect 20x, wait. Taking capital at a valuation you resent creates misalignment with investors and sets up future conflict.
Indian market context: what differs
Fundraising dynamics in India have specific nuances:
Regulatory compliance matters more
Investor due diligence in India scrutinizes GST compliance, FEMA filings, and statutory audit more rigorously than in the US. Fundraising with unresolved compliance gaps delays closing by 2-3 months or kills deals entirely.
Valuations compress faster in downturns
Indian venture markets are shallower than US markets. When sentiment turns, Series A valuations can drop 40-60% in 6 months. Founders optimizing for peak valuations face structural down-round risk.
Exits take longer
IPO timelines in India are 8-12 years post-founding (vs. 6-8 years in the US). M&A exits are smaller and less frequent. Investors with shorter fund lifecycles may push for premature liquidity.
Key takeaway
Fundraising is not about timing the market or matching competitor announcements. It is about understanding when external capital unlocks growth that internal financing cannot support — and ensuring that growth justifies the dilution.
Founders who raise from strength, deploy capital efficiently, and reach clear inflection points maximize value. Those who raise reactively, burn indiscriminately, and miss milestones compound dilution without creating proportional returns.